13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SC Filed 2022-02-08 Event — SEC 0001193125-22-031107 →

Bain Capital Life Sciences Fund II, L.P. Mersana Therapeutics, Inc.

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
9 13D/G filings on this issuer
8 other filings besides this one
Filer Track Record
10 filings by this filer
9 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $300K
Point72 Asset Mgmt

Other 13D/G Filings on Mersana Therapeutics, Inc.

FiledFormFilerStakeShares
2026-01-08 SCHEDULE Bain Capital Life Sciences Fund II, L.P. view →
2022-04-14 SC Bain Capital Life Sciences Fund II, L.P. view →
2022-01-03 SC Bain Capital Life Sciences Fund II, L.P. view →
2021-01-12 SC Bain Capital Life Sciences Fund II, L.P. view →
2020-12-10 SC New Enterprise Associates 14, L.P. view →
2020-11-19 SC New Enterprise Associates 14, L.P. view →
2020-09-22 SC New Enterprise Associates 14, L.P. view →
2020-04-24 SC New Enterprise Associates 14, L.P. view →

Other Filings by Bain Capital Life Sciences Fund II, L.P.

FiledFormIssuerStakeShares
2026-01-08 SCHEDULE Mersana Therapeutics, Inc. view →
2024-04-12 SC Savara Inc SVRA view →
2023-07-19 SC Savara Inc SVRA view →
2022-04-14 SC Mersana Therapeutics, Inc. view →
2022-01-03 SC Mersana Therapeutics, Inc. view →
2021-09-24 SC Atea Pharmaceuticals, Inc. AVIR view →
2021-09-03 SC Atea Pharmaceuticals, Inc. AVIR view →
2021-03-17 SC Savara Inc SVRA view →
2021-01-12 SC Mersana Therapeutics, Inc. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →